Trump's Bold Move: Executive Order to Slash Prescription Drug Prices

**Trump's Executive Order Aims to Slash Prescription Drug Prices** Washington, D.C. – In a surprise move, President Donald Trump signed an executive order on May 12, 2025, aimed at drastically reducing the cost of prescription medications in the United States. The order utilizes a "most favored nation" pricing model, aligning US drug prices with the lowest prices paid in other developed countries. Dr. Zain Hasan, a prominent commentator on healthcare policy, explains, "This executive order could potentially shift the balance of power from large pharmaceutical companies to the average American." He notes that the immediate impact will be felt primarily by those using Medicare and Medicaid, as well as weight-loss medications. However, the order faces potential legal challenges. Pharmaceutical giants like Merck and Pfizer have voiced concerns about the impact on research and development. The courts will play a critical role in determining the final outcome of this ambitious policy initiative. The long-term effects remain uncertain, but the executive order represents a significant step in the ongoing debate over prescription drug affordability in the US. The coming months will be crucial in determining the success of this bold initiative and its impact on the healthcare landscape.